You are here

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomas

 

Online download statistics by month:

Online download statistics by month: August 2023 to January 2026

AbstractFullPdf
Aug 2023540550153
Sep 202319019035
Oct 202313813946
Nov 202314915048
Dec 202311511851
Jan 2024737449
Feb 2024787836
Mar 2024989839
Apr 2024878744
May 2024788047
Jun 2024828144
Jul 2024898959
Aug 20245453165
Sep 2024747444
Oct 2024828243
Nov 2024656736
Dec 202410610734
Jan 2025686933
Feb 2025828244
Mar 2025767638
Apr 2025777836
May 2025565726
Jun 2025323216
Jul 2025110
Dec 2025550
Jan 2026001
Total249525171167